CN103301506B - 一种抗凝血丝素膜及其制备方法 - Google Patents
一种抗凝血丝素膜及其制备方法 Download PDFInfo
- Publication number
- CN103301506B CN103301506B CN201310251819.0A CN201310251819A CN103301506B CN 103301506 B CN103301506 B CN 103301506B CN 201310251819 A CN201310251819 A CN 201310251819A CN 103301506 B CN103301506 B CN 103301506B
- Authority
- CN
- China
- Prior art keywords
- fibroin
- anticoagulation
- hirudin
- preparation
- silk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010022355 Fibroins Proteins 0.000 title claims abstract description 154
- 239000012528 membrane Substances 0.000 title claims abstract description 74
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 230000010100 anticoagulation Effects 0.000 title claims description 71
- 229940006607 hirudin Drugs 0.000 claims abstract description 44
- 102000007625 Hirudins Human genes 0.000 claims abstract description 43
- 108010007267 Hirudins Proteins 0.000 claims abstract description 43
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 claims abstract description 43
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000008367 deionised water Substances 0.000 claims abstract description 20
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 20
- 239000000853 adhesive Substances 0.000 claims abstract description 19
- 230000001070 adhesive effect Effects 0.000 claims abstract description 19
- 239000011259 mixed solution Substances 0.000 claims abstract description 10
- 238000003756 stirring Methods 0.000 claims abstract description 9
- 239000012460 protein solution Substances 0.000 claims description 29
- 239000002202 Polyethylene glycol Substances 0.000 claims description 18
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 claims description 18
- 229920001223 polyethylene glycol Polymers 0.000 claims description 18
- 241000255789 Bombyx mori Species 0.000 claims description 13
- 239000004793 Polystyrene Substances 0.000 claims description 12
- 229920002223 polystyrene Polymers 0.000 claims description 12
- 230000008014 freezing Effects 0.000 claims description 6
- 238000007710 freezing Methods 0.000 claims description 6
- 239000003517 fume Substances 0.000 claims description 5
- 125000003368 amide group Chemical group 0.000 claims description 4
- 238000007711 solidification Methods 0.000 claims description 4
- 230000008023 solidification Effects 0.000 claims description 4
- 238000000502 dialysis Methods 0.000 claims description 3
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 claims description 2
- 238000003763 carbonization Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 claims description 2
- 230000002429 anti-coagulating effect Effects 0.000 abstract description 11
- 239000003146 anticoagulant agent Substances 0.000 abstract description 10
- 229940127219 anticoagulant drug Drugs 0.000 abstract description 10
- 230000008901 benefit Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 abstract 2
- 238000007605 air drying Methods 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 22
- 239000008280 blood Substances 0.000 description 22
- 239000000463 material Substances 0.000 description 20
- 206010018910 Haemolysis Diseases 0.000 description 17
- 230000008588 hemolysis Effects 0.000 description 17
- 210000002381 plasma Anatomy 0.000 description 17
- 210000001772 blood platelet Anatomy 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 239000002473 artificial blood Substances 0.000 description 8
- 210000004204 blood vessel Anatomy 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 229960002897 heparin Drugs 0.000 description 7
- 229920000669 heparin Polymers 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 6
- 230000002949 hemolytic effect Effects 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- 238000004026 adhesive bonding Methods 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 238000011049 filling Methods 0.000 description 5
- 239000012620 biological material Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 2
- 238000010041 electrostatic spinning Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 108010013296 Sericins Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 229920004933 Terylene® Polymers 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- GDESEHSRICGNDP-UHFFFAOYSA-L [Cl-].[Cl-].[Ca+2].CCO Chemical compound [Cl-].[Cl-].[Ca+2].CCO GDESEHSRICGNDP-UHFFFAOYSA-L 0.000 description 1
- 239000003519 biomedical and dental material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310251819.0A CN103301506B (zh) | 2013-06-21 | 2013-06-21 | 一种抗凝血丝素膜及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310251819.0A CN103301506B (zh) | 2013-06-21 | 2013-06-21 | 一种抗凝血丝素膜及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103301506A CN103301506A (zh) | 2013-09-18 |
CN103301506B true CN103301506B (zh) | 2015-03-04 |
Family
ID=49127510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310251819.0A Active CN103301506B (zh) | 2013-06-21 | 2013-06-21 | 一种抗凝血丝素膜及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103301506B (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103721300B (zh) * | 2013-12-19 | 2015-05-20 | 华中科技大学 | 一种抗凝血涂层材料及其制备方法 |
CN106729944A (zh) * | 2016-11-25 | 2017-05-31 | 江苏爱西施科技服务咨询股份有限公司 | 一种具有镇痛消炎功效的丝素蛋白缝合线及其制备方法 |
CN106730052B (zh) * | 2017-02-27 | 2020-04-07 | 苏州大学 | 一种丝素蛋白抗凝血材料及其制备方法 |
CN106693082B (zh) * | 2017-02-27 | 2020-05-22 | 苏州大学 | 一种抗凝血材料及其制备方法 |
CN106902398B (zh) * | 2017-02-27 | 2020-05-22 | 苏州大学 | 阳离子化丝素蛋白材料、其制备方法及应用 |
CN110038162B (zh) * | 2019-04-16 | 2021-08-31 | 苏州大学 | 一种具有调控血管细胞生长作用的功能丝素材料及其制备方法 |
CN110075309B (zh) * | 2019-04-16 | 2022-09-06 | 苏州大学 | 一种具有调控血管细胞生长作用的丝素膜及其制备方法 |
CN110003518B (zh) * | 2019-04-16 | 2021-08-31 | 苏州大学 | 一种活性丝素蛋白多孔材料或活性丝素蛋白膜及其制备方法 |
CN110025828B (zh) * | 2019-04-16 | 2021-07-30 | 苏州科技城医院 | 一种功能丝素蛋白多孔材料或功能丝素蛋白膜及其制备方法 |
CN112043877B (zh) * | 2020-08-06 | 2022-10-14 | 苏州大学 | 一种蚕丝抗凝血管支架覆膜及其制备方法 |
CN114887123B (zh) * | 2022-04-18 | 2023-07-04 | 南通大学 | 水蛭素接枝纳米纤维血管支架材料、制备方法与应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1608683A (zh) * | 2003-10-20 | 2005-04-27 | 北京理工大学 | 一种抗凝血性不溶性丝素材料的制备方法 |
CN1799649A (zh) * | 2005-12-09 | 2006-07-12 | 清华大学 | 一种血液相容性生物材料及其制备方法 |
CN101264342A (zh) * | 2008-02-25 | 2008-09-17 | 北京理工大学 | 丝素蛋白小口径血管 |
CN101837149A (zh) * | 2010-06-18 | 2010-09-22 | 华中科技大学 | 一种抗凝血抗菌生物医用材料及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3642003A (en) * | 1969-08-26 | 1972-02-15 | Sutures Inc | Sutures having long-lasting germicidal properties |
EP0352330A4 (en) * | 1987-11-02 | 1990-03-27 | Terumo Corp | FIBROIN MOLDINGS, PREPARATION METHOD, HEPARIN IMMOBILIZATION MEDIUM, AND PREPARATION METHOD. |
-
2013
- 2013-06-21 CN CN201310251819.0A patent/CN103301506B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1608683A (zh) * | 2003-10-20 | 2005-04-27 | 北京理工大学 | 一种抗凝血性不溶性丝素材料的制备方法 |
CN1799649A (zh) * | 2005-12-09 | 2006-07-12 | 清华大学 | 一种血液相容性生物材料及其制备方法 |
CN101264342A (zh) * | 2008-02-25 | 2008-09-17 | 北京理工大学 | 丝素蛋白小口径血管 |
CN101837149A (zh) * | 2010-06-18 | 2010-09-22 | 华中科技大学 | 一种抗凝血抗菌生物医用材料及其制备方法 |
Non-Patent Citations (2)
Title |
---|
丝素/羧甲基纤维素膜力学性能研究;闻荻江;《纺织学报》;20040831;第25卷(第4期);第7-9页 * |
新型抗凝血药物的研究进展;武云强等;《现代生物医学进展》;20120630;第12卷(第16期);第3198页左栏第1段、右栏第2段 * |
Also Published As
Publication number | Publication date |
---|---|
CN103301506A (zh) | 2013-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103301506B (zh) | 一种抗凝血丝素膜及其制备方法 | |
CN103285431B (zh) | 一种抗凝血丝素材料及其制备方法 | |
Aytemiz et al. | Small‐diameter silk vascular grafts (3 mm diameter) with a double‐raschel knitted silk tube coated with silk fibroin sponge | |
CN103418022B (zh) | 一种复合多功能生物止血材料及其制备方法 | |
CN105521520B (zh) | 一种家蚕丝素止血材料的制备方法 | |
CN108744055B (zh) | 一种丝素蛋白骨水泥生物粘合剂及其制备方法 | |
JPH0636818B2 (ja) | コラ−ゲン合成血管移植組織 | |
CN114344556A (zh) | 一种多酚-丝素蛋白-聚乙二醇医用组织胶黏剂、制备方法及应用 | |
CN106310366B (zh) | 一种引导牙周组织再生屏障膜及其制备方法与应用 | |
CN1919354A (zh) | 人造血管丝素、胶原蛋白共混预凝涂层 | |
Sun et al. | Hemocompatibility and cytocompatibility of the hirudin‐modified silk fibroin | |
CN106693082B (zh) | 一种抗凝血材料及其制备方法 | |
Wang et al. | Coagulation/anticoagulation-regulable and tough extracellular matrix hydrogels | |
CN106730052B (zh) | 一种丝素蛋白抗凝血材料及其制备方法 | |
JPWO2019155391A5 (zh) | ||
CN106902398B (zh) | 阳离子化丝素蛋白材料、其制备方法及应用 | |
CN1919355A (zh) | 人造血管胶原蛋白预凝涂层 | |
CN108778353A (zh) | 人工复合膜、制备方法及其应用 | |
Wang et al. | Fabrication and performance evaluation of PLCL-hCOLIII small-diameter vascular grafts crosslinked with procyanidins | |
CN103920187B (zh) | 一种丝素蛋白和脱钙骨基质复合的骨修复材料 | |
CN110464871A (zh) | 一种可注射水凝胶及其制备方法 | |
Du et al. | Improved hemocompatibility by modifying acellular blood vessels with bivalirudin and its biocompatibility evaluation | |
EP2279014B1 (en) | Extracellular matrix comprising platelet factors | |
CN114053486B (zh) | 一种可吸收生物活性膜及其制备方法和用途 | |
Mahanani et al. | The Effects of Platelet Rich Plasma Incorporation Towards Swelling Profile and Gel Fraction of Synthetic Coral Scaffold |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171116 Address after: 215501 Jiangsu Province, Changshou City high tech Industrial Development Zone Magi Road No. 88 Patentee after: Changshu Zijin Intellectual Property Service Co., Ltd. Address before: 215000 Suzhou Industrial Park, Jiangsu Road, No. 199 Patentee before: Soochow University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180104 Address after: 215000 Suzhou Industrial Park, Jiangsu Road, No. 199 Patentee after: Soochow University Address before: 215501 Jiangsu Province, Changshou City high tech Industrial Development Zone Magi Road No. 88 Patentee before: Changshu Zijin Intellectual Property Service Co., Ltd. |
|
TR01 | Transfer of patent right |